Cesar Arias

An enriching experience to talk about AMR at the "Editors in Conversation" podcast in India with Prof. Anuradha Chowdhary (@UnivofDelhi) and hosted by Prof. Cesar A. Arias @SuperBugDoc Link: youtu.be/G1KtS6MSjHs?si… @ASMicrobiology

Countdown to IMARI 2026, Pre-meeting workshop : Microbiomes as Reservoirs, Catalysts, and Solutions for AMR. Outstanding Speakers (Drs Derick Crook, Cesar De La Fuente, Ashley Earl, Mary Hayden and Michael Woodworth. @IDSAInfo @ASMicrobiology imari.org

The draft for the 2026 IDSA/ESCMID clinical practice guidelines on 𝘚. 𝘢𝘶𝘳𝘦𝘶𝘴 bacteraemia is now available for public consultation. Get your copy of the manuscript and submit your feedback before 15 December 2025. ow.ly/aJmE50XwVYb

Determining minimum inhibitory concentrations (MICs) is essential for evaluating antimicrobial efficacy. How to optimize the process? This #AACJournal study tests reducing broth microdilution assay volumes w/o compromising MIC accuracy. Get the results: asm.social/2Fy

Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations | Antimicrobial Agents and Chemotherapy (pmc.ncbi.nlm.nih.gov/articles/PMC12…) @SuperBugDoc @ASMicrobiology

IMARI 2026New Antimicrobial Agents Session featuring that are in or entering clinical development.  Deadline: December 1, 2025, by 2:00 p.m. ET  Notification: December 17, Eligibility Requirements at IMARI.org

High-risk clonal expansion of IMP-producing Enterobacter cloacae complex in regional Japanese healthcare settings | Antimicrobial Agents and Chemotherapy (journals.asm.org/doi/10.1128/aa…) @SuperBugDoc @ASMicrobiology

New issue #AACJournal now out incluidng a minireview of Achromobacter infections, Targeting CARD9 with Small-Molecule Therapeutics, safety of omadacycline in patients with hepatic impairment and much more... @ASMicrobiology @ARLGnetwork aac.asm.org/content/64/11?…

Deadline for abstract submission @ASMicrobiology @IDSAInfo #IMARI2026 is tomorrow October 1.. Amazing program already in place.. Two outstanding pre-meeting workshops on Pk/PD and Genomics/Microbiome and AMR imari.org

Abstract deadline for the @ASMicrobiology and @IDSAInfo IMARI 2026 (Interdisciplinary Meeting on Antimicrobial Resistance & Innovation) in Las Vegas, NV is October 1 Registration now OPEN!! @asm_tmc @ARLGnetwork imari.org

How does Pseudomonas aeruginosa colistin resistance evolve in biofilms? Researchers shine a light on this question in #AACJournal, uncovering similarities and differences in the dynamics of colistin resistance under biofilm and planktonic growth. asm.social/2AW

@SuperBugDoc 🙌🏼

In the latest episode of Editors in Conversation, we discuss the raise of measles, cliniucal manifestations and mitigation measure with truly outstanding experts in the field @ASMicrobiology @asm_tmc asm.org/podcasts/edito…

Journal reviewers are the core of our scientific mission. #AACJournal celebrates our top reviewers and would be eternally grateful for their contributions @ASMicrobiology

Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidence. doi.org/10.1128/aac.00…

Recognizing Dr. Murray’s significant contributions to the field of #InfectiousDisease, the @ARLGnetwork renamed our Early Stage Investigator award in her honor. Dr. Murray's commitment to the field will live on through researchers receiving this award. @UTHealthHouston

Website of IMARI (Interdisciplinary Meeting on Antimicrobial Resistance and Innovation; January 28-30, 2026, Las Vegas!) imari.org @ASM and @IDSAInfo. Abstract submission now OPEN Deadline: Wednesday, October 1, Dispositions: October 22 @ARLGnetwork

Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS) ✅ Just Accepted ✍️ @SuperBugDoc @MethodistHosp 🔗 bit.ly/44mEiOb